Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Industry News
Share your love
Six Cases of Retinal Vasculitis Reported with Syfovre Use
After the initial approval of Apellis Pharmaceuticals’ geographic atrophy drug Syfovre (pegcetacoplan injection), six cases of retinal vasculitis have been reported. The ASRS Research and Safety in Therapeutics (ReST) Committee issued a notification disclosing these safety concerns to ASRS members,…
Eye Drops vs. Eye İnjections for Retinal Vein Occlusion
A recent study conducted by Columbia University researchers suggests that newly developed eye drops could potentially offer a more effective and comfortable treatment option for a common eye disease currently managed through eye injections. The eye disease in question is…
EU Eases Contact Lens UDI Requirements
The European Commission has approved a revision to the EU Medical Device Regulation (MDR) to streamline the Unique Device Identifier (UDI) requirements for specific products, starting with contact lenses. Once implemented, the amendment will enable contact lens manufacturers to assign…
Cellusion Secures $21 Million Funding
Cellusion, a Tokyo-based biotech company, announced the successful completion of its Series C Round financing, raising an impressive 2.83 billion yen, equivalent to $21 million. The primary focus of this funding is to accelerate the advancement of Cellusion’s lead program,…
Hans Jürgen Thier Named as Germany CM at VSY Biotech
Andreas Kühnel, Managing Director of VSY Biotechnology, headquartered and legally based in Leinfelden-Echterdingen, announced the appointment of Hans Jürgen Thier as the new Country Manager for Germany. Kühnel announced that exports from VSY Biotechnology in Germany have substantially increased by…
Pharmedica USA Recalls Purely Soothing 15% MSM Drops
Pharmedica USA has issued a worldwide recall for two lots of Purely Soothing, 15% MSM Drops, at the consumer level due to non-sterility concerns. The use of contaminated eye drops can pose a risk of eye infections and vision loss.…
FDA Nods Miebo by Bausch + Lomb and Novaliq for DED
Bausch + Lomb announced that the FDA has granted approval for Miebo (perfluorohexyloctane ophthalmic solution; previously referred to as NOV03) to treat the signs and symptoms of dry eye disease (DED). Miebo is the first and only FDA-approved treatment for…
How to diagnose Papilledema, A Swollen Optic Nerve?
Papilledema is the swelling of the optic nerve as it enters the back of the eye due to raised intracranial pressure. Fluid surrounding the brain is constantly produced and reabsorbed, maintaining just enough intracranial pressure to help protect the brain…
Iris Trauma Repair I OBN
The colorful portion of the eye, the iris, is made up of a ring of muscle and connective tissue fibers that contract and stretch to open and close the pupil in response to the intensity of ambient light. The iris,…
Refractive Market to Generate $12 Billion
According to Market Scope’s recent report, the global refractive surgery market will generate $12 billion in total retail revenue in 2027, up from $8.9 billion in 2022, representing a 6.2% compound growth rate. Revenue at the manufacturing level is expected…